T2 Biosystems, Inc. announced On November 1, 2022, Alec Barclay notified T2 Biosystems, Inc. of his resignation as Chief Operations Officer of the Company, effective as of November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.74 USD | -6.14% |
|
-11.24% | -24.46% |
25/06 | T2 Biosystems Signs Exclusive Distribution Deal for Hong Kong, Macau | MT |
25/06 | T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.46% | 80.89M | |
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B | |
+13.21% | 28.61B |
- Stock Market
- Equities
- TTOO Stock
- News T2 Biosystems, Inc.
- T2 Biosystems, Inc. Announces Resignation of Alec Barclay as Chief Operations Officer, Effective November 30, 2022